Compare Pfizer with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs SUVEN LIFESCIENCES - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER SUVEN LIFESCIENCES PFIZER/
SUVEN LIFESCIENCES
 
P/E (TTM) x 33.3 19.7 169.1% View Chart
P/BV x 5.6 4.0 139.9% View Chart
Dividend Yield % 0.6 0.5 115.5%  

Financials

 PFIZER   SUVEN LIFESCIENCES
EQUITY SHARE DATA
    PFIZER
Mar-18
SUVEN LIFESCIENCES
Mar-19
PFIZER/
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs2,365338 700.3%   
Low Rs1,625169 959.3%   
Sales per share (Unadj.) Rs430.352.1 825.4%  
Earnings per share (Unadj.) Rs78.76.8 1,152.2%  
Cash flow per share (Unadj.) Rs93.28.6 1,087.3%  
Dividends per share (Unadj.) Rs20.001.50 1,333.3%  
Dividend yield (eoy) %1.00.6 169.5%  
Book value per share (Unadj.) Rs586.565.3 898.3%  
Shares outstanding (eoy) m45.75127.28 35.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.64.9 95.3%   
Avg P/E ratio x25.337.1 68.3%  
P/CF ratio (eoy) x21.429.6 72.4%  
Price / Book Value ratio x3.43.9 87.6%  
Dividend payout %25.422.0 115.7%   
Avg Mkt Cap Rs m91,27132,272 282.8%   
No. of employees `0002.61.1 243.1%   
Total wages/salary Rs m3,143661 475.3%   
Avg. sales/employee Rs Th7,484.86,132.2 122.1%   
Avg. wages/employee Rs Th1,195.0611.1 195.6%   
Avg. net profit/employee Rs Th1,369.1803.5 170.4%   
INCOME DATA
Net Sales Rs m19,6856,635 296.7%  
Other income Rs m1,143242 471.7%   
Total revenues Rs m20,8286,877 302.9%   
Gross profit Rs m5,0031,604 311.9%  
Depreciation Rs m663221 299.2%   
Interest Rs m438 11.1%   
Profit before tax Rs m5,4791,587 345.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,878718 261.6%   
Profit after tax Rs m3,601869 414.2%  
Gross profit margin %25.424.2 105.1%  
Effective tax rate %34.345.2 75.8%   
Net profit margin %18.313.1 139.6%  
BALANCE SHEET DATA
Current assets Rs m24,1676,232 387.8%   
Current liabilities Rs m9,5441,490 640.5%   
Net working cap to sales %74.371.5 103.9%  
Current ratio x2.54.2 60.5%  
Inventory Days Days5586 63.7%  
Debtors Days Days2983 34.7%  
Net fixed assets Rs m9,5144,043 235.3%   
Share capital Rs m458127 359.4%   
"Free" reserves Rs m26,3758,183 322.3%   
Net worth Rs m26,8328,310 322.9%   
Long term debt Rs m2518 140.4%   
Total assets Rs m36,90010,389 355.2%  
Interest coverage x1,305.543.1 3,028.7%   
Debt to equity ratio x00 43.5%  
Sales to assets ratio x0.50.6 83.5%   
Return on assets %9.88.7 111.9%  
Return on equity %13.410.5 128.3%  
Return on capital %20.419.5 104.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m225,622 0.4%   
Fx outflow Rs m1,4891,799 82.7%   
Net fx Rs m-1,4663,822 -38.4%   
CASH FLOW
From Operations Rs m3,318356 933.3%  
From Investments Rs m-2,383-279 855.3%  
From Financial Activity Rs m-1,104-225 490.2%  
Net Cashflow Rs m-169-148 113.7%  

Share Holding

Indian Promoters % 0.0 63.4 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 0.0 -  
FIIs % 4.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 36.5 64.9%  
Shareholders   85,207 37,287 228.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   IPCA LABS  NOVARTIS  DR. DATSONS LABS  PROCTER & GAMBLE HEALTH  GSK PHARMA  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Higher; Tata Steel & Bajaj Finance Top Gainers(12:30 pm)

Share markets in India are presently trading on a positive note, tracking gains in global peers. US President Donald Trump said he did not want war.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Sep 18, 2019 12:27 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS